Zentralbl Gynakol 2003; 125(1): 17-22
DOI: 10.1055/s-2003-40364
Originalarbeit

© Georg Thieme Verlag Stuttgart · New York

Reduction or elimination of postoperative pain medication after mastectomy through use of a temporarily placed local anaesthetic pump vs. control group

Reduktion oder Elimination von postoperativer Schmerzmedikation nach Mastektomie durch Benutzung einer temporär platzierten Lokalanästhetikapumpe im Vergleich mit Kontrollgruppe J. E. Morrison Jr.1 , V. R. Jacobs1, 2
  • 1Department of General Surgery, Fayette Medical Center, Fayette, Alabama, USA
  • 2Frauenklinik (OB/GYN), Technical University Munich, Munich, Germany
Further Information

Publication History

Publication Date:
01 July 2003 (online)

Abstract

Objective: We evaluated the efficacy of a temporarily placed porous catheter with continuous application of a local anaesthetic (ON~Q® by I-Flow-Corp., Lake Forest, CA, USA) post mastectomy vs. patients without this device regarding postoperative need for opioid medication.
Material and Methods: At Fayette Medical Center, Alabama, a retrospective evaluation of all consecutive mastectomies (n=49) within a five-year-period from 1/1997-12/2001 and statistical analysis regarding postoperative need for opioids was performed. The ON~Q pain management pump with continuous 0.25 % Sensorcaine® (Bupivacaine and Epinephrine) application for about 72 h (n=22) was compared vs. a control group without pain management pump (n=27).
Results: There were no statistical significant differences regarding patient demographics in both groups. Patients in the ON~Q group with no need of postoperative opioid pain medication were: 18.2 vs. 3.7 % (P=0.1), no need for opioids after postoperative day 1: 68.2 % vs. 11.1 % (P < 0.001), total opioids usage in dose equivalents (DE): 1.25 vs. 3.36 DE (-62.8 %) (P=0.016), opioids usage postoperative day 1: 0.65 vs. 1.82 DE (-64.6 %) (P=0.016), opioids usage postoperative day 2: 0.24 vs. 0.75 DE (-68.4 %) (P=0.011). The length of stay in hospital was 2.35 vs. 2.93 days (n. s.), and postoperative stay in PACU: 38.4 vs. 43.3 min (n. s.). OR time for placement of catheter and pump is only slightly increased. No complications occurred.
Conclusion: Use of an ON~Q pain management pump could significantly reduce or even eliminate postoperative need for opioids analgesics.

Zusammenfassung

Fragestellung: Wir untersuchten die Wirkung eines zeitlich befristet platzierten, porösen Katheters mit kontinuierlicher Applikation eines Lokalanästhetikums (ON~Q® Pain Management System von I-Flow-Corp., Lake Forest, CA, USA) nach Mastektomie im Vergleich zu einer Kontrollgruppe ohne Katheter bezüglich des postoperativen Bedarfes an Opioid-Schmerzmedikation.
Material und Methode: Am Fayette Medical Center in Alabama wurde eine retrospektive Untersuchung aller konsekutiver Mastektomien (n =49) innerhalb eines 5-Jahres-Zeitraumes von Januar 1997 bis Dezember 2001 mit statistischer Analyse des Opioid- Schmerzmittelverbrauches durchgeführt und die beiden Gruppen: 1. ON~Q Pain Management Pump Gruppe mit kontinuierlicher 0,25 % Sensorcaine® (Bupivacain und Epinephrin) Applikation über ca. 72 h (n=22) mit 2. der Kontrollgruppe ohne Schmerzmittelpumpe (n=27) verglichen.
Ergebnisse: Beide Gruppen wiesen bezüglich der Patientendaten keine statistisch signifikanten Unterschiede auf. In der ON~Q-Gruppe benötigten weniger Patienten postoperativ keine Opioide: 18,2 zu 3,7 % (P=0,1), hatten keinen Opioidbedarf nach dem 1. postoperativen Tag: 68,2 zu 11,1 % (p < 0,001). Der gesamte Opioidverbrauch in Dosisequivalenten (DE) war in der ON~Q Gruppe reduziert: 1,25 zu 3,36 DE (-62,8 %) (p=0,016), wie auch der Opioidverbrauch am 1. postoperativen Tag: 0,65 zu 1,82 DE (- 64,6 %) (p=0,016) und 2. postoperativen Tag: 0,24 zu 0,75 DE (-68,4 %) (p= 0,011). Die Länge des Krankenhausaufenthaltes betrug 2,35 zu 2,93 Tagen (n. s.) und die Dauer der postoperativen Überwachung 38,4 zu 43,3 min (n. s.). Die OP-Zeit zur Applikation der ON~Q-Schmerzpumpe war nur geringfügig verlängert; es gab keine Komplikationen in der Anwendung.
Schlussfolgerung: Die Verwendung des ON~Q Pain Management Systems kann den postoperativen Bedarf von Opiaten zur Analgesie nach Mastektomie signifikant reduzieren oder sogar vermeiden.

References

  • 1 Ault A. Suing for pain relief. http://www.cancerpage.com/cancernews/cancernews2724.htm (accessed on 18.09.2002)
  • 2 Macrae W A. Chronic pain after surgery.  Br J Anaesth. 2001;  87 88-98
  • 3 Tasmuth T, Kataja M, Blomqvist C, von Smitten K, Kalso E. Treatment-related factors predisposing to chronic pain in patients with breast cancer - a multivariate approach.  Acta Oncol. 1997;  36 625-630
  • 4 Carpenter J S, Sloan P, Andrykowski M A, McGrath P, Sloan D, Rexford T, Kenady D. Risk factors for pain after mastectomy/lumpectomy.  Cancer Practice. 1999;  7 66-70
  • 5 Smith W C, Bourne D, Squair J, Phillips D O, Chambers W A. A retrospective cohort study of post mastectomy pain syndrome.  Pain. 1999;  83 91-95
  • 6 Kwekkeboom K. Postmastectomy pain syndromes.  Cancer Nurs. 1996;  19 37-43
  • 7 Shenfeld O, Eldar I, Lotan G, Avigad I, Goldwasser B. Intraoperative irrigation with bupivacaine for analgesia after orchiopexy and herniorrhaphy in children.  J Urol. 1995;  153 185-187
  • 8 Tverskoy M, Cozacov C, Ayache M, Bradley EL J r, Kissin I. Postoperative pain after inguinal herniorraphy with different types of anesthesia.  Anesth Analg. 1990;  70 29-35
  • 9 Fong S Y, Pavy T J, Yeo S T, Paech M J, Gurrin L C. Assessment of wound infiltration with bupivacaine in women undergoing day-case gynecological laparoscopy.  Reg Anesth Pain Med. 2001;  26 131-136
  • 10 Weber A, Munoz J, Garteiz D, Cueto J. Use of subdiaphragmatic bupivacaine instillation to control postoperative pain after laparoscopic surgery.  Surg Laparosc Endosc. 1997;  7 6-8
  • 11 Pettersson N, Perbeck L, Hahn R G. Efficacy of subcutaneous and topical local anesthesia for pain relief after resection of malignant breast tumors.  Eur J Surg. 2001;  167 825-830
  • 12 Saleh A, Fox G, Felemban A, Guerra C, Tulandi T. Effects of local bupivacaine instillation on pain after laparoscopy.  J Am Assoc Gynecol Laparosc. 2001;  8 203-206
  • 13 Johnson N, Onwude J L, Player J, Hicks N, Yates A, Bryce F, Tuffnell D, Jarvis G, MacDonald H, Griffiths-Jones M. et al . Pain after laparoscopy: an observational study and a randomized trail of local anesthetic.  J Gynecol Surg. 1994;  10 129-138
  • 14 Yarussi A, Sands R, Edge S, Lema M J, de Leon-Casasola O A. Evaluation of peripheral morphine analgesia for lumpectomy and axillary node dissection: a randomized, double-blind, placebo-controlled study.  Reg Anesth Pain Med. 1999;  24 142-145
  • 15 Johansson A, Axelson J, Ingvar C, Luttropp H H, Lundberg J. Preoperative ropivacaine infiltration in breast surgery.  Acta Anaesthesiol Scand. 2000;  44 1093-1098
  • 16 Zimberg S E. ON~Q post-operative pain relief system in elective abdominal hysterectomy surgery, a pilot clinical outcomes study evaluating length of stay, post-operative pain, narcotic analgesia use and the impact on costs and adverse effects. 50th Annual Meeting of the American Colleague of Obstetrics and Gynecology (ACOG), Los Angeles, CA, USA, May 4th-8th 2002
  • 17 Shahin M S, Sanders L, Sood A K. Phase II study of ON~Q Pain management System in patients undergoing surgery for gynecologic malignancy. 30th Annual Clinical Meeting of the Western Association of Gynecologic Oncologists, June 6th-9th 2001
  • 18 Ashcraft E E, Baillie G M, Shafizadeh S F, McEvoy J R, Mohamed H K, Lin A, Baliga P K, Rogers J, Rajagopalan P R, Chavin K D. Further improvements in laparoscopic donor nephrectomy: decreased pain and accelerated recovery.  Clin Transplantation. 2001;  15 (Suppl 6) 59-61
  • 19 Savioe F H, Field L D, Jenkins R N, Mallon W J, Phelps 2nd R A. The pain control infusion pump for postoperative pain control in shoulder surgery.  Arthroscopy. 2000;  16 339-342
  • 20 Stringer N H, Rodino K L, Edwards M, Kumari N VA. ON~Q system for managing trocar site pain after operative laparoscopy.  J Am Assoc Gynecol Laparosc. 2000;  7 (4) 552-555
  • 21 Hebel S K, Burnham T H. Drug Facts and Comparisons. Wolver Cluiver, St. Louis, MO, USA, 1996
  • 22 Wilder-Smith C H, Schuler L. Postoperative analgesia: pain by choice? The influence of patient attitudes and patient education.  Pain. 1992;  50 257-262
  • 23 Dine A P. Surgical site infection rates reduced with the use of continuous incisional infusion of local anesthetic. 50th Annual Meeting of the Association of Perioperative Registered Nurses, Chicago, IL, USA, March 23rd-27th 2003
  • 24 Carpenter R L. Optimizing postoperative pain management.  Am Fam Phys. 1997;  56 (3) 835-844

Dr. Volker R. Jacobs

Frauenklinik der Technischen Universität München

Ismaninger Str. 22

81675 München

Phone: 0 89/41 40-24 20

Fax: 0 89/41 40-48 31

Email: volkerjacobs@hotmail.com

    >